India, Oct. 29 -- D2C nutrition and dietary supplements brand Ace Blend has raised $9.9 Mn (about Rs.95 Cr) in a Series A2 funding round led by 3one4 Capital, with participation from existing investor Fireside Ventures.

The startup will use the fresh capital for clinical trials, supply chain improvements, R&D, and new nutrition formats.

"The first is clinical trials, which are going to be run by credible CROs (contract research organisations) and are intended to be published in peer-reviewed international journals. The second is cementing our moat as a business, which is our supply chain proficiency. The third is a robust testing mechanism that allows nutritional accuracy, pesticides and heavy metals to be tested batch on batch without ...